MedPath

Intraoperative Music to PROMote PaTient oUtcome (IMPROMPTU): a double-blind, placebo-controlled, randomized multicenter trial

Recruiting
Conditions
Esophageal cancer, Esophagectomy, gastric cancer, gastrectomy, music, perioperative patient care, stress response to surgery.Slokdarmkanker, slokdarmresectie, maagkanker, maagresectie, muziek, perioperatieve patientenzorg, chirurgische stress respons
Registration Number
NL-OMON23998
Lead Sponsor
Erasmus MC, University Medical Center Rotterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
70
Inclusion Criteria

In order to be eligible to participate in this study, a subject must meet all of the following criteria:
1.Patients undergoing elective surgical esophageal or stomach cancer resection
2.Age ≥ 18 years
3.Provision of written informed consent by the patient

Exclusion Criteria

A potential subject who meets any of the following criteria will be excluded from participation in this study:
1.Patients using systemic steroid, immunosuppressant or cytotoxic medication at the moment of music intervention
2.Known hearing impairment or use of an hearing aid
3.Insufficient knowledge of the Dutch language to understand the study documents in the judgement of the attending physician or researcher
4.Objection to any unknown music
5.Patients with locally advanced, unresectable esophageal or stomach cancer

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome is postoperative pain (Numeric Rating Scale (NRS)).
Secondary Outcome Measures
NameTimeMethod
Secondary outcomes are intraoperative medication requirement (intraoperative propofol, opioids and catecholamines), postoperative opioid requirement, stress response to surgery (serum cortisol, tumor necrosis factor alpha (TNF-α), interleukin-6 (IL-6), C-reactive protein (CRP)), intraoperative vital parameters, postoperative complications, hospital length of stay and 30-day mortality.
© Copyright 2025. All Rights Reserved by MedPath